Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MORE: Olmesartan Atherosclerosis Regression Evaluation
NCT00185185Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Nov 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olmesartan in atherosclerosis, hypertension (HTN), sponsored by Daiichi Sankyo Co., Ltd.. Started Nov 2001; status: completed.
02
Drugs
olmesartan
03
Conditions
atherosclerosishypertension (HTN)
Beyond the preview
Go deeper on NCT00185185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00185185.